Doctor Kim Bouillon
French National Agency for Medicines and Health Products Safety (ANSM), Saint Denis (France)
Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Antithrombotic therapy in atrial fibrillation 1
ESC 365 is supported by
